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Abstract
Background: ACT is an effective community treatment but causes discontinuity of care between
acutely ill and currently stable patient groups. The Dutch variant of ACT, FACT, combines both
intensive ACT treatment and care for patients requiring less intensive care at one time point yet
likely to need ACT in the future. It may be hypothesised that this case mix is not beneficial for
patients requiring intensive care, as other patient groups may "dilute" care provision. The
effectiveness of FACT was compared with standard care, with a particular focus on possible
moderating effects of patient characteristics within the case mix in FACT.
Methods: In 2002, three FACT teams were implemented in a Dutch region in which a cumulative
routine outcome measurement system was in place. Patients receiving FACT were compared with
patients receiving standard treatment, matched on "baseline" symptom severity and age, using
propensity score matching. Outcome was the probability of being in symptomatic remission of
psychotic symptoms.
Results: The probability of symptomatic remission was higher for SMI patients receiving FACT
than for controls receiving standard treatment, but only when there was an unmet need for care
with respect to psychotic symptoms (OR = 6.70, p = 0.002; 95% CI = 1.97 – 22.7).
Conclusion: Compared to standard care, FACT was more rather than less effective, but only
when a need for care with respect to psychotic symptoms is present. This suggests that there is no
adverse effect of using broader patient mixes in providing continuity of care for all patients with
severe mental illness in a defined geographical area.
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Background
The Dutch schizophrenia guidelines recommend assertive
community treatment (ACT) as the primary service provi-
sion for people who have a severe mental illness (SMI)
and are reluctant to work with mental health care services
[1]. Earlier studies and the literature review underlying
this recommendation have shown that ACT is superior to
standard treatments in a wide range of clinical and service
outcomes [1-6], but these studies originate primarily from
the US.
In The Netherlands, a Dutch variant of ACT was devel-
oped: 'function-ACT' (FACT) [7]. FACT teams are deliver-
ing service for the total group of SMI patients in a region,
where ACT only covers the 20% most severely ill sub-
group. In FACT teams, care intensity can be upgraded
when needed. Therefore, FACT combines two approaches
within one multidisciplinary recovery-oriented team: (a)
individual case management and home visits for extensive
care SMI-patients who are mostly stable; (b) shared
caseload with intensive full ACT approach for patients in
need for intensive care. The latter group receives care
according to ACT directives including daily review in staff
meetings. When, over time, the care needs of these
patients change, they remain in the same multidiscipli-
nary team (continuity of care). Members of FACT teams
conduct a style of assertive outreach by paying both
announced and unannounced home visits to both groups
of patients, and by using supportive legal measures when
needed [8]. Compared to ACT, FACT is a more versatile
and comprehensive care system with continuity of care as
an important component. The FACT teams are in charge
during both outpatient episodes and admission and
decide on discharge [7]. Thus, FACT teams serve a diverse
population of SMI patients with various levels of need for
care. On the other hand, "classic" ACT serves only those
SMI patients who are in crisis or have the highest needs for
care. As intensive care patients need more guidance than
more stable patients do, the average frequency of contacts
in a FACT team is lower and the number of patients per
team is higher than in an ACT team. Although FACT was
developed for the Dutch mental health care system, it has
been noted that its features may also be applicable in
other countries, such as the U.S. [9].
Only a few European studies have assessed effectiveness of
ACT or FACT. In Europe, effects of ACT are not as positive
as suggested in early U.S. work. Some European studies
have found a beneficial effect for ACT in length and
number of hospitalizations [10-14], continuity of care
[11,15-17], psychopathology [18-21], social functioning
[19] or housing stability ([14]. However, these beneficial
effects are not always significantly superior to the effect of
other community-based treatments. In The Netherlands,
Dekker and colleagues [12] conducted one of the few RCT
studies of the effectiveness of Dutch ACT teams. They
compared SMI patients receiving either ACT or standard
outpatient treatment on number and length of hospital
admissions, general functioning, psychopathology and
social behaviour. A large reduction in number of bed days
was seen for the experimental condition in comparison to
the control group after two years of ACT, but no differ-
ences between ACT and the control treatment were found
for any of the other outcome variables [12]. In another
Dutch RCT study of the effectiveness of ACT, the primary
outcome was loss to follow-up over a period of two years
[17]. This study showed that FACT was significantly better
than standard care in maintaining contact with patients.
However, the decrease in drop-out rates of FACT patients
was not reflected in any of the clinical outcome variables,
such as psychopathology, social functioning and quality
of life. In contrast to these two Dutch studies, Bak and col-
leagues [18] did find an effect of FACT on a clinical out-
come [18]. In a mirror-image study, they compared the
number of patients with a psychotic disorder who were
making the transition to symptomatic remission before
and after the introduction of FACT in Maastricht, and
found that the probability of going into symptomatic
remission increased by 15% (Number Needed to Treat)
after the introduction of FACT. After controlling for possi-
ble confounders, this risk difference decreased only
slightly – namely to 12% – although it was no longer sta-
tistically significant.
A reason for the less positive results in Europe when com-
pared with the U.S. could be that in studies where com-
parative (standard) mental health practice is poor, effect
sizes of ACT are higher [10,22]. When ACT was developed
in the U.S., patients were discharged into a community
with almost no mental health care [23]. Standard treat-
ment was either expensive hospital care for a few or noth-
ing at all for most patients. In Europe, a reasonably well-
developed community-based mental health service exists
as the 'standard' treatment. In addition, in FACT the focus
of treatment is the community rather than the hospital,
not only for the 80% less intensive SMI patients but for all
SMI patients. The aim is that the more severely ill SMI
patients also benefit from social inclusion in the commu-
nity [7]. In addition, outpatient SMI patients can access
resources needed for recovery and rehabilitation that were
often only available for hospital patients.
Currently, more than 60 FACT (and 25 ACT) teams are in
operation in the Netherlands (population 16.4 million);
an increase to 200 FACT teams is expected [7]. As more
FACT teams are being set up in The Netherlands it is
important to assess whether FACT is more effective than
other community-based treatments in targeting SMI
patients. As stated above, FACT teams serve a heterogene-
ous population. Because of this heterogeneity, it can beBMC Psychiatry 2008, 8:93 http://www.biomedcentral.com/1471-244X/8/93
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questioned whether effectiveness of FACT is the same for
all FACT-patients. As far as we know, it has never been
studied whether FACT is beneficial for all patients receiv-
ing it. The FACT-specific case mix of patients needing
either intensive or extensive care may "dilute" care and
create poorer outcome for patients with the most treat-
ment needs. Therefore, effect modification between FACT
and need for care on symptoms and self-care as well as
between FACT and functioning may be hypothesized. In
addition, SMI patients with comorbid alcohol addiction
(dual disorder patients) are a more severe subgroup
within the FACT population, possibly more difficult to
treat. For example, it has been shown that these patients
more often use crisis services and are hospitalised and
involuntarily admitted more frequently [24,25].
The present observational study was set up to assess the
effectiveness of FACT in the south of the Netherlands.
Although the design of RCT studies is sound, the research
requirements can limit the external validity and generaliz-
ability to different settings. The effectiveness of psychoso-
cial interventions such as FACT depends on
environmental factors – such as time per patient, type of
mental health organization and compliance to the treat-
ment protocol – much more than pharmacological com-
pounds do [22,26,27]. While RCT studies assess treatment
effectiveness in theory, effectiveness in practice should
additionally be studied in observational studies that do
not manipulate the environment. Therefore, an observa-
tional study was chosen over an RCT.
The present study was an extension of the study of Bak
and colleagues [18]. Instead of a pre-post mirror-image
study design, which may be confounded by changing cir-
cumstances over time, it compared the probability of
being in symptomatic remission for patients receiving
FACT versus similarly affected patients receiving standard
treatment. It was hypothesized that patients receiving
FACT have a higher probability of being in symptomatic
remission over a period of time than patients receiving
standard treatment. In addition, given the FACT-specific
case mix of patients we examined to what degree effective-
ness may be differential depending on factors determin-
ing the intensiveness of need for care, including:
functioning/self-care treatment needs, substance use
needs (as indicators for dual disorder), psychotic symp-
tom treatment needs and level of chronicity (new in care,
2–3 years in care, chronic).
Methods
Since 2002, three FACT teams have been set up in Maas-
tricht and surrounding areas in the province of Limburg,
which is in the south of the Netherlands. These teams
serve all SMI patients living independently, in sheltered
accommodation or in an open psychiatric hospital ward
[8]. Standard treatment of patients with SMI – the control
condition – includes inpatient treatment, sheltered resi-
dential treatment and community treatment with broker-
type case management.
PCR and CNCR
The data for the present study were obtained from a
merged database consisting of the Psychiatric Case Regis-
ter (PCR) and the Cumulative Needs for Care Register
(CNCR). The PCR registers the consumption of mental
health care of psychiatric patients in South Limburg (pop-
ulation 660 000). Data for the PCR have been provided by
all regional mental health facilities for all patients since
1981 [28]. The CNCR monitors the need for care of
patients with SMI in South Limburg. The data for the
CNCR have been collected in Maastricht since 1998 and
in the other regions of South Limburg since 2004. Data
are cumulatively and routinely collected in clinical prac-
tice with intervals of 1 to 2 years and with every major
change in treatment or setting. There is no specific base-
line in the flow of the illness history and the number of
follow-up measurements differs per person as this is a nat-
uralistic study [29]. For the present analyses, the CNCR
and PCR were anonymously matched using a case identi-
fication code with an encryption algorithm and the date
of the CNCR interview [18] and values of the first assess-
ment after 2002 were used as a proxy for baseline values.
CNCR interview
A CNCR interview [29] provides information on (i)
demographic variables, (ii) current level of psychopathol-
ogy, (iii) level of general functioning, (iv) needs for care,
v) quality of life (5 items) and vi) quality of care (1 item).
Psychopathology was assessed using the Brief Psychiatric
Rating Scale (BPRS). The BPRS [30] is a semi-structured
interview assessing the presence and severity of various
symptoms in the two weeks preceding the interview. The
BPRS items are scored on a 7-point Likert scale (1 = not
present; 7 = most severe). Ratings are based upon clinical
observations of symptoms and patients' verbal report of
symptoms. In order to standardize the ratings, anchor
points and probe questions are described for each item
[29,30]. Factor analyses of the BPRS have revealed the
existence of four underlying constructs ('BPRS scales'):
negative symptoms, positive symptoms, manic excite-
ment and depression/anxiety [31]. The BPRS items
blunted affect, motor retardation, emotional withdrawal
and self-neglect loaded on negative symptoms; bizarre
behaviour, unusual thought content, disorientation, hal-
lucinations and suspiciousness loaded on positive symp-
toms; motor hyperactivity, elevated mood, excitement,
distractibility, hostility and grandiosity loaded on manic
excitement; and depression, anxiety, suicidal ideation and
guilt loaded on depression/anxiety.BMC Psychiatry 2008, 8:93 http://www.biomedcentral.com/1471-244X/8/93
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Need for care was assessed using the Camberwell Assess-
ment of Need (CAN) [32]. Baseline values of a few indi-
vidual items were used in the present paper (see statistical
analysis) because the sum score lacks validity and, there-
fore, is likely of less value [33]. The CAN includes 22 items
(e.g. daytime activities, psychotic symptoms). All CAN
items can be scored 0 (no problem), 1 (there was a prob-
lem, but the problem is met), 2 (unmet need) with a ref-
erence period including the last 3 months [8]. In the
CNCR, information from clinician and patient is com-
bined using a priori decision rules to maximise the clinical
relevance of the rating.
Information on the global functioning of patients was
obtained with the extended Global Assessment of Func-
tioning (GAF) scale [34]. This tool consists of a psychopa-
thology scale (GAF-p, sample range 1–95), rating the
global symptom severity of patients, and an impairment
scale (GAF-i range 1–95), rating their level of impairment
in psychosocial functioning.
Outcome measure
The primary outcome measure was symptomatic remis-
sion of psychotic disorder. Symptomatic remission is
defined as a symptom intensity level within the normal
general population range, reflecting negligible influence
on an individual's functioning [35]. For the objective
measurement of symptomatic remission the following 7
BPRS items are included [35,36]: 1) grandiosity, 2) suspi-
ciousness, 3) unusual thought content, 4) hallucinatory
behaviour, 5) conceptual disorganization, 6) mannerism/
posturing and 7) blunted affect [35,36]. These BPRS items
are diagnostically specific to psychotic disorders. They
reflect both the three dimensions of psychopathology
underlying psychotic disorders (psychoticism, disorgani-
zation, negative symptoms) and the five acute phase crite-
ria of schizophrenia in the DSM IV (delusions,
hallucinations, disorganization, disorganized or catatonic
behaviour, negative symptoms) [35,36]. In order to be
classified as being in symptomatic remission, patients had
to score 3 or less on all 7 BPRS items [35,36].
Subjects and matching
Data of SMI patients collected between April 2002 (the
start of FACT in the Maastricht region) and August 2007
were included in the matching procedure. Of the matched
patients, data up to December 2007 were included in the
multilevel analyses (see below). Patients were classified as
SMI patients if they fit the diagnosis of schizophrenia or
psychotic disorder (DSM-IV 295, 297 or 298), or had a
minimal score of 15 on the positive symptom scale of the
BPRS on any of the assessments. Additionally, patients
with a low level of functioning (below 45 on at least one
of the GAF scales) and a minimum of 2 needs in the
domains of accommodation, welfare benefits, alcohol
and drugs, were classified as SMI patients [33]. These four
domains of needs were a priori selected from the 22 CAN
domains. Because services for alcohol and drug addiction
did not take part in the data collection, patients with sub-
stance abuse disorder with no further psychiatric disorders
were not included. As the definition was to a degree arbi-
trary and an absolute cut-off may be too strict, the group
of patients scoring below 45 on one of the two GAF scales
and a need in 1 of the 4 above-mentioned CAN domains
was also included in the analyses as moderately mentally
ill (MMI) rather than SMI patients. All patients not meet-
ing the above criteria for MMI and SMI were excluded
from the analyses, even if they were treated by a FACT-
team.
Next, all patients ever identified by either the PCR or the
CNCR as receiving FACT were coded as FACT patients.
FACT patients are a more severely ill subgroup of all
patients in the CNCR database. Consequently, patients
coded as receiving FACT were matched with controls,
using propensity score nearest neighbour-matching (one
on one) with replacement. Propensity scores were based
on age category (18–30, 31–65, 66+), the two GAF-scales
and the four BPRS sum scores (all continuous variables).
The FACT group included Maastricht patients only, while
Maastricht patients were excluded when selecting
matched controls, because all Maastricht patients who
were eligible for FACT were already served by one of the
FACT teams. Before matching, FACT patients differed sig-
nificantly from all non-FACT patients with respect to age
(mean age FACT-patients 38 years, others 43 years) and
GAF (mean symptoms FACT-patients 52.9, others 50.7).
Positive symptoms and negative symptoms were higher in
the FACT group and depression/anxiety was lower, but
differences were not statistically significant. After the
matching, matching variables were more balanced than
before, although there was still a small difference in age
(mean 37 years vs 39 years, p = 0.08).
Statistical analysis
All analyses were performed using the statistical program
Stata 10 [37]. Since the data consisted of multiple meas-
urements per patient and the patients were matched the
observations were not independent. As a result, standard
logistic regression techniques could not be used for statis-
tical analysis of the data. The data with measurements
(level 1) clustered in subjects (level 2) clustered in
matched groups (level 3) were, therefore, subjected to
multilevel logistic regression analysis, which is ideally
suited for analysis of this type of data [38]. The xtmelogit
command is the logistic regression variant of the Stata
xtmixed command with 2 or more levels. The group level
was added to control for clustering in the data introduced
by the matching. The dependent variable was sympto-
matic remission (yes/no) a variable at measurement level,BMC Psychiatry 2008, 8:93 http://www.biomedcentral.com/1471-244X/8/93
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while the independent variable was FACT (yes/no). Age,
symptom severity at baseline (four BPRS continuous vari-
ables), functioning at baseline (two GAF scales, continu-
ous) and gender were included in the models as
independent variables.
In addition, interaction terms between FACT and a set of
baseline variables as outlined earlier were included in the
model: GAF symptoms and handicap, level of chronicity,
CAN alcohol, CAN drugs, CAN psychotic symptoms and
CAN self care. When any of these interaction terms was
statistically significant (alpha was set at 0.05) the Stata
Lincom procedure was used to calculate odds ratios of
FACT and remission for all strata of the interaction varia-
bles.
Results
Two-hundred forty patients receiving FACT were matched
with two-hundred controls. FACT-patients were on aver-
age 2.7 times (range 1–8) and non FACT-patients 2.3
times assessed (range 1–5). Table 1 presents the character-
istics and the remission status of the patients.
Analyses showed statistically significant positive interac-
tion between FACT and baseline need for care with respect
to psychotic symptoms (χ2 = 12.62, df = 2, p = 0.002) and
a significant negative interaction between FACT and base-
line need for care with respect to alcohol (χ2 = 6.74, df =
2, p = 0.03). Thus, FACT patients with an unmet need in
psychotic symptoms were more often in remission at fol-
low-up than non-FACT patients (OR = 6.70, p = 0.002;
95% CI = 1.97 – 22.7, table 2). If additionally the interac-
tion with need for care with respect to alcohol use was
taken into account, the odds increased further: remission
was more than 8 times more likely in those with unmet
need for psychotic symptoms and absence of a need with
respect to alcohol use (OR = 8.52).
Discussion
Results of the present study showed that, within the sub-
group of patients with an unmet need for care with respect
to psychotic symptoms at baseline, patients receiving
FACT were more likely to be in remission than were
patients receiving standard treatment. This suggests that
FACT makes a difference in patients for whom either the
patient or the clinician recognises an unmet need in this
area. However, a coexisting alcohol problem precluded
any associations with FACT.
A first explanation for only finding an association
between FACT and remission in patients scoring an unmet
need on psychotic symptoms could be that these patients
may be the most severely ill. The conclusion that FACT is
more effective than standard care for the high care patient
subgroup and should be restricted to these patients, could
be a consequence of a "regression to the mean" effect.
However, if severity was the only explanation, we would
have expected an interaction between severity of symp-
toms and FACT. Post hoc, an interaction term between
FACT and BPRS positive symptoms was added to the
regression model. This interaction term was statistically
imprecise by conventional alpha, while the interaction
between FACT and CAN psychotic symptoms remained.
In addition, patients with an unmet need in psychotic
symptoms are not per definition the most severely ill [see
[29]], although it is likely that severely ill psychotic
patients will have a need for care on that item. This is ver-
ified by the correlation between unmet need with respect
to psychotic symptoms and BPRS positive symptoms,
which is relatively high, but not perfect (r2 = 0.6) and
higher than the other three BPRS sum scores (r2 between
0.17 and 0.21, all correlations p < 0.001).
There are several other explanations for finding an associ-
ation in patients with an unmet need with respect to psy-
chotic symptoms, only. First, in standard care, a patient
with a need for care with respect to psychotic symptoms is
treated by a single professional, often a psychiatrist who
provides medication to manage symptom exacerbation.
In FACT, a multidisciplinary team provides treatment for
all SMI-patients rather than only for those SMI patients
who need intensive care. This team includes a psychiatrist,
psychologists, addiction workers, case managers and
vocational rehabilitation workers using Individual Place-
ment and Support (IPS). Professionals from the multidis-
ciplinary team start treatment in their area of expertise, in
parallel to the psychiatrist who reduces psychotic symp-
toms. Because of the continuity-of-care principle these
interventions are continued when crises are managed.
Second, over the years, some ACT related principles
became 'good practice' references and were included in
standard care. This could be a reason why no extra benefi-
cial effects could be shown in the group of patients with-
out a need for care with respect to psychotic symptoms.
The present study also showed that a need for care in the
area of alcohol precluded the beneficial effects of FACT.
Patients with alcohol dependence do not seem to benefit
from FACT. This is not in line with a previous study show-
ing that high fidelity to ACT (including dual disorder
treatment) is of particular importance for substance abuse
outcomes in dual disorder patients ([39]. In Maastricht
the fidelity to ACT guidelines is acceptable (see below),
but addiction 'specialists' were not yet available during
the study assessment period. SMI patients with comorbid
alcohol addition may be more difficult to treat than other
SMI patients, resulting in increased use of crisis services
and higher percentages of self-harm [24]. In a London
study, dual disorder patients were more often hospitalisedBMC Psychiatry 2008, 8:93 http://www.biomedcentral.com/1471-244X/8/93
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Table 1: Demographic and diagnostic characteristics of the non-FACT and FACT patients
Non-FACT patients (n = 200) FACT patients (n = 240)
Remission at assessment (%) 123 (61.8)1 153 (63.8%)1
Men (%) 125 (62.5) 145 (61.4)
Ever SMI
SMI (%) 141 (70.5) 200 (83.7)
MMI (%) 59 (29.5) 39 (16.3)
Baseline:
Remission (%) 108 (54.3) 118 (49.2)
Level of chronicity
New 22 (13.4) 19 (11.7)
2–3 years 14 (8.5) 12 (7.4)
Chronic 128 (78.1) 131 (80.9)
Need for care psychotic symptoms
No 75 (38.5) 62 (26.7)
Met 79 (40.5) 111 (47.8)
Unmet 41 (21.0) 59 (25.4)
Need for care alcohol
No 146 (76.0) 189 (80.1)
Met 27 (14.0) 25 (10.6)
Unmet 19 (9.9) 22 (9.3)
Age
Mean (SD) 39.3 (12.2) 37.3 (11.8)
Range 19–77 18–81
GAF Psychopathology
Mean (SD) 53.8 (15.8) 53.3 (15.9)
Range 5–90 15–95
GAF Impairment
Mean (SD) 51.6 (13.7) 50.5 (15.0)
Range 20–81 18–95
BPRS Depression/anxiety
Mean (SD) 9.9 (4.5) 9.6 (4.6)
Range 4–23 4–23
BPRS positive symptoms
Mean (SD) 9.5 (5.1) 9.6 (4.4)
Range 5–33 5–26
BPRS negative symptoms
Mean (SD) 6.7 (3.1) 6.6 (3.1)
Range 4–25 4–21
BPRS manic excitement
Mean (SD) 9.7 (4.3) 9.4 (3.8)
Range 6–36 6–23
1 Note that remission is assessed at measurement-level and a patient can be in remission at one moment and not in remission at another and, 
therefore, the numbers add up to more than the total number of patients.BMC Psychiatry 2008, 8:93 http://www.biomedcentral.com/1471-244X/8/93
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or involuntary admitted and the authors speculated that
these patients might benefit from specific interventions,
such as a specialized FACT team for dual disorder patients
[25]. Fidelity guidelines for FACT-teams in the Nether-
lands do list Integrated Dual Diagnosis Treatment as a
core feature and FACT-teams in other Dutch regions did
integrate these. Currently Integrated Dual Diagnosis
Treatment is progressively implemented in the Maastricht
FACT teams. It is expected that this would improve out-
comes for dual disorder patients.
Other European and recent US studies showed less
impressive effect sizes than the present study [12,17,19-
21]. The focus of FACT on early detection of symptom
exacerbation to prevent more serious symptomatology,
may explain the difference [7]. Another reason could be
fidelity, because lower fidelity has been associated with a
lower effectiveness [6,14,39]. Preliminary results using
the DACTS – a scale measuring ACT fidelity [40] showed
that two Maastricht FACT teams had acceptable scores on
fidelity for ACT, while a third team had a moderate score
(personal communication Van Vugt). A post-hoc analysis
restricted to patients of the two teams with acceptable
fidelity and their matched controls showed associations
between FACT and symptomatic remission that were sim-
ilar to the original analysis (in patients with an unmet
need on psychotic symptoms: OR = 7.06; p = 0.004; 95%
confidence interval = 1.8 – 27.1, n = 88; in patients with
both an unmet need on psychotic symptoms and no need
with respect to alcohol: OR = 8.39, p = 0.003, 95% CI =
2.11 – 33.4, n = 67). Recently, a Dutch expert group
embedded in the Centre for Certification ACT & FACT
http://www.ccaf.nl evaluated working ingredients and for-
mulated fidelity criteria to evaluate FACT rather than ACT.
This resulted in the development of a FACT Fidelity Scale
(FACTs) and currently field tests are being conducted.
As a result of the integrated patient mix in FACT, it was
impossible to isolate the cases within the FACT-teams that
were effectively receiving ACT in the present study. There-
fore, this is one of the first FACT outcome studies. Further
research is needed to replicate the present results. These
future studies should include interaction terms and they
should assess and control for the fidelity of the FACT
teams. It is also important that future studies clearly
describe the ingredients of FACT as well as standard treat-
ment, so that effective elements can be identified.
In sum, results of the present study support the recom-
mendation of the Dutch schizophrenia guidelines, which
recommend ACT as the primary treatment for people with
SMI [1]. Within the Dutch mental health care system this
can be operationalised by starting FACT teams. The addi-
tion of an addiction specialist to the teams may improve
benefits for patients with a coexisting alcohol problem.
Although only patients with an unmet need on psychotic
symptoms seemed to benefit from FACT, we feel that all
patients with or without an unmet need in this area
should remain in FACT, because continuity of care is an
important feature, probably contributory to the effective-
ness of FACT.
Methodological issues
The strength of the present study is the unique data collec-
tion, as real-life observational data were obtained longitu-
dinally within the treatment process and interviews were
conducted by different interviewers in different settings.
This might increase the generalizability of the results.
Table 2: Odds ratio's (95% confidence intervals) of FACT when studying remission, depending on baseline need for care on psychotic 
symptoms
need for care at baseline: psychotic symptoms
no met unmet
0.35* (0.14 – 0.87)
n = 137
1.07 (0.55 – 2.05)
n = 190
6.70** (1.97 – 22.7)
n = 100
need for care at baseline: alcohol
no 0.54 (0.21 – 1.37)
n = 100
1.43 (0.72 – 2.84)
n = 156
8.52** (2.43 – 29.8)
n = 75
met 0.16* (0.03 – 0.80)
n = 19
0.42 (0.09 – 1.97)
n = 21
2.50 (0.43 – 14.6)
n = 10
unmet 0.07** (0.01 – 0.43)
n = 17
0.19 (0.03 – 1.04)
n = 13
1.12 (0.15 – 8.31)
n = 11
* p < 0.05
** p < 0.01BMC Psychiatry 2008, 8:93 http://www.biomedcentral.com/1471-244X/8/93
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However, it can also threaten reliability. To minimize this
threat, a manual for the assessment of the interviews was
developed, interviewers were trained on a regular basis
(booster sessions) and new mental health care profession-
als received supervision in the scoring of CNCR inter-
views. Another possible threat to the reliability of the data
collection is that the interviewers were the mental health
care workers involved in the treatment of the subjects and
that they were not blinded for the treatment condition.
This is, however, hypothesized not to pose a big threat to
reliability as the assessment of CNCR interviews were in
place years before the introduction of the FACT teams and
were never positioned in an evaluation of FACT.
A second important strength of the present study is its out-
come measure. Symptomatic remission has been shown
to be a clinically meaningful concept and is a feasible out-
come measure [36]. The outcome measures most com-
monly used in studies of the effectiveness of ACT/FACT
are the number and/or length of hospital admissions
([10,17,19,27,41], but several studies have shown that
these outcomes correlate more with the number of availa-
ble beds than with the service that is being delivered
[27,41]. Consequently, the present study used a clinical
outcome measure. However, the definition of full remis-
sion, rather than symptomatic remission, is not only
based on 7 BPRS items, but also includes a time criterion:
symptom levels should remain low for at least 6 months.
This time criterion could not be incorporated because
only a few patients in this sub sample were measured
more than twice and observations were mostly more than
1 year apart. Bak and colleagues showed in a sensitivity
analysis that when remission was defined as scoring low
on the 7 BPRS items at two successive moments, results
were even stronger than the original results [18]. There-
fore, it is likely that including the time criterion would
have shown similar or even stronger results in favour of
FACT, rather than weaker effect sizes.
In addition, this is a naturalistic study of regular clinical
practice and the CNCR started in 2004 in the control
region, while the first FACT team was established in 2002.
Therefore, data from FACT patients and their matched
controls could be a maximum of two years apart and the
first included assessment occurred after FACT introduc-
tion. Furthermore, some best-match controls contributed
only one assessment. Analyses may have been methodo-
logically more sound if changes since baseline were ana-
lysed, by controlling for remission at baseline and
excluding the baseline assessment. Two other ACT studies
studied changes in symptom severity [12,17] and these
studies did not show any effect. However, according to
Andreasen and colleagues [35] 'the real-world interpreta-
bility of change scores as a primary outcome is limited
because of the variability of baseline symptom severity
across intervention trials'.
The current data differ from those used by Bak and col-
leagues [18] because information from the PCR as well as
the CNCR was used to identify which patient actually
received FACT. However, the data of the merged PCR and
CNCR databases did not always concur with respect to
service delivery: some patients were identified as being a
FACT patient in one database but not in the other. There-
fore, a person was assigned to the FACT group if he/she
was classified as receiving FACT at least once in either of
the databases. One reason for these differences is that PCR
data from the second half of 2006 and from 2007 were
not available yet. Although it is possible that some FACT
patients were missed, none of these FACT patients were
included in the control group, because these were
obtained from an adjacent region.
Propensity score matching is a relatively new method of
matching which can be used in observational data where
treated subjects differ systematically from controls [42].
However, this type of matching can be performed in sev-
eral different ways and it is unclear which option is the
best. Therefore, we performed nearest neighbour match-
ing both with and without replacement [43]. Fortunately,
results of the different analyses were rather similar. In
addition, an extra level was included in the multilevel
analyses to control for the matching [42].
The present study has some other limitations. First, non-
FACT patients originated from an adjacent region in
which FACT had not yet been introduced. However, the
South Limburg patient population is similar in the two
sub regions and stable over time. Therefore, invalidation
of the results is negligible.
Second, matching, using the first measurement after the
start of FACT could have obscured the effect of FACT
(FACT patients and controls are similar because the
patients outcomes already improved). The current analy-
sis strategy is the best possible to obtain ecologically valid
results and the reported association between FACT and
remission cannot be a result of the matching using first
measurement data.
Third, the CNCR protocol prescribes that CNCR inter-
views should be carried out at intake, as part of the yearly
evaluation, and at every mutation in the patient's care
plan. However, due to pragmatic and logistic reasons, pro-
fessional carers do not always comply exactly. It is possi-
ble that members of FACT-teams are better compliers than
professional carers in standard treatment, because the
CNCR interview is implemented within FACT. In addi-
tion, FACT aims to serve patients throughout their courseBMC Psychiatry 2008, 8:93 http://www.biomedcentral.com/1471-244X/8/93
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of illness, also offering low-profile supportive care while
standard care patients with the same severity of the symp-
toms are transferred to a less intensive type of care. There-
fore, patients in remission may be interviewed more often
when served by a FACT-team and this could explain part
of the effect reported in the present paper. However,
reminders are routinely sent to all interviewers who do
not turn in the yearly reassessment and by matching
CNCR data with PCR data it is in future also possible to
send reminders with every mutation in treatment. Unfor-
tunately, this feedback procedure has a delay of some
months. Furthermore, the management in the control
region enforces the professional carers to fill in the CNCR
forms. Finally, the helpdesk in the control region is very
strict in sending reminders and professional carers are also
personally approached if necessary. Therefore, we feel that
the difference in compliance cannot be that large to fully
explain the positive findings.
Furthermore, reliability of the GAF at the individual level
is not sufficient and this could lead to random misclassi-
fication in the propensity scores [44]. Some FACT patients
may, therefore, not have been matched to the "closest"
control patient. However, because this misclassification is
random it only leads to noise and a larger confidence
interval, while the effect size remains.
Despite the limitations, it is a unique study that combines
the merits of an observational study with a careful statisti-
cal procedure, resulting in promising results for FACT in
the Netherlands.
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